Page last updated: 2024-11-06

prednisolone and Pyelonephritis, Xanthogranulomatous

prednisolone has been researched along with Pyelonephritis, Xanthogranulomatous in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Pyelonephritis, Xanthogranulomatous: A chronic inflammatory condition of the KIDNEY resulting in diffuse renal destruction, a grossly enlarged and nonfunctioning kidney associated with NEPHROLITHIASIS and KIDNEY STONES.

Research Excerpts

ExcerptRelevanceReference
"Past medical history includes type 2 diabetes mellitus, transient ischaemic attack, hypertension, non-alcoholic fatty liver disease, dyslipidaemia, osteoarthritis and active smoking."1.91Metastatic xanthogranulomatous pyelonephritis managed with immunosuppression. ( Chrysostomou, A; Daniell, J; Pedagogos, E, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Daniell, J1
Pedagogos, E1
Chrysostomou, A1

Other Studies

1 other study available for prednisolone and Pyelonephritis, Xanthogranulomatous

ArticleYear
Metastatic xanthogranulomatous pyelonephritis managed with immunosuppression.
    Nephrology (Carlton, Vic.), 2023, Volume: 28, Issue:9

    Topics: Diabetes Mellitus, Type 2; Humans; Immunosuppression Therapy; Male; Nephrectomy; Prednisolone; Pyelo

2023